Back

Double or triple antithrombotic therapy for patients with atrial fibrillation undergoing percutaneous coronary intervention: not a matter of faith

European Heart Journal - Cardiovascular Pharmacotherapy

19 December 2020
Organised by: Logo
Read full article
ESC Journals

Contributors

Mattia Galli
Mattia Galli

Author

Felicita Andreotti
Felicita Andreotti

Author

Domenico D’Amario
Domenico D’Amario

Author

Filippo Crea
Filippo Crea

Author

Italo Porto
Italo Porto

Author

IRCCS Policlinic San Martino Genoa , Italy

You may be interested in
thumbnail
Congress Presentation
Meta-analysis of clinical trials comparing triple versus dual antithrombotic therapy on risk reduction of stent thrombosis after percutaneous coronary intervention in atrial fibrillation patients
27 August 2021
thumbnail
Webinar
The year in cardiology 2018
12 December 2018
thumbnail
Webinar
Antithrombotic strategy for ACS: from default to alternative strategies. ESC 2023 Clinical Practice Guidelines - Webinar Series
28 November 2023
thumbnail
Congress Session
Atrial fibrillation and cancer: what you should do
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources